Stock Market News

Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal

Apr 30, 2025 - 17:28
 0
Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal
Read More

Tags:

Previous Article

Airbus tops Q1 expectations as production set to ramp up

Next Article

Trump says IBM and Raytheon might get contract to modernize air traffic controll...

Related Posts

Kering sales drop 14% in first quarter as Gucci crisis deepens

Kering sales drop 14% in first quarter as Gucci crisis ...

Apr 23, 2025  0

FTSE 100 today: British stocks gain at open as key U.K. companies report earnings

FTSE 100 today: British stocks gain at open as key U.K....

Apr 30, 2025  0

Walgreens to pay $300 million in settlement over U.S. opioid allegations

Walgreens to pay $300 million in settlement over U.S. o...

Apr 21, 2025  0